The current COVID-19 (coronavirus) crisis sweeping the world is having a hugely disruptive impact on society and business, and our first thoughts and best wishes are with our clients, colleagues and their families who are facing this unprecedented public health challenge.
The financial services regulatory issues you might face during the COVID-19 crisis will depend on the type and makeup of your organisation, your company constitution, your organisation’s purpose, key members and stakeholders.
As a consequence of the epidemiological emergency caused by COVID-19 (coronavirus), the Italian Government and the Italian Banking Association (ABI) have approved a number of measures to support micro, small- and medium-sized companies (SMEs) (as defined by the European Commission Recommendation No. 2003/361/EC of May 6, 2003 ), facing the economic impact of COVID-19.
The COVID-19 pandemic is having wide ranging and deep effects on companies in all sectors. In this context, publicly traded companies need to consider their ongoing disclosure obligations.
The Italian Government has adopted a number of measures aimed at protecting the health and welfare of the people and ensuring the survival of businesses in Italy.
In response to the mounting COVID-19 (coronavirus) crisis, the CSA announced on March 18, 2020, that it will provide blanket relief to a broad group of market participants, including registrants and investment funds, to accommodate a 45-day extension from some regulatory filings required to be made on or before June 1, 2020.
We are all being forced to navigate the many challenges stemming from the rapid spread of COVID-19 (novel coronavirus).
COVID-19 (coronavirus) has had an early and extreme effect on the aviation industry.
German companies of different sizes and industry sectors may face considerable liquidity problems due to the impact of COVID-19 (coronavirus) in a market where insolvency rules are very strict.
Industry:
Subscribe and stay up to date with the latest legal news, information and events . . .
Top
© Norton Rose Fulbright LLP 2023